PALMOPLANTAR PUSTULOSIS
Clinical trials for PALMOPLANTAR PUSTULOSIS explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection tested for painful hand and foot blisters
Disease control CompletedThis study tested whether an experimental drug called ANB019 (imsidolimab) could reduce painful blisters and scaling on the palms and soles in adults with palmoplantar pustulosis. 59 participants received either the drug or a placebo injection to compare safety and effectiveness …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
AI steps in to help doctors spot rare skin diseases
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors diagnose skin conditions more accurately, especially rare ones like generalized pustular psoriasis. Fifteen doctors reviewed 100 patient images, first giving their own diagnosis and then seeing the …
Matched conditions: PALMOPLANTAR PUSTULOSIS
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Doctors track Real-World treatment for painful skin condition
Knowledge-focused CompletedThis study aimed to understand how palmoplantar pustulosis (PPP), a chronic skin condition causing painful blisters on hands and feet, is treated in real-world Japanese clinics. Researchers observed 276 patients already starting or receiving standard systemic medications to see h…
Matched conditions: PALMOPLANTAR PUSTULOSIS
Sponsor: Janssen Pharmaceutical K.K. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC